You are here

credit rating

S&P expects steady erosion in Big Pharma's credit profile in 2021 as new M&A deals roll in — but don't underestimate their underlying strength

Endpoints

Thu, 02/25/21 - 09:59 am

pharma industry

Moody's: Pharma sell-offs put credit ratings at risk

Fierce Pharma

Wed, 05/4/11 - 11:34 am

Drugmaker's Acquisitions to Weigh on Credit Ratings, Moody's Analysts Say

Bloomberg

Wed, 11/17/10 - 11:44 am

Pharma execs expect fines, M&A and easier credit

Fierce Pharma

Wed, 05/19/10 - 05:02 pm

Pharma Debt Is Outstripping Growth In Cash

Pharmalot

Fri, 04/16/10 - 09:56 am

pharma industry

Moody's says big pharma credit ratings are at risk

Yahoo/AP

Thu, 04/15/10 - 03:38 pm

Moody's raises Teva credit rating

Yahoo/AP

Thu, 01/14/10 - 04:13 pm

Teva Pharmaceuticals